Benchmark Reaffirms Speculative Buy Rating for Milestone Scientific (NYSE:MLSS)

Benchmark reiterated their speculative buy rating on shares of Milestone Scientific (NYSE:MLSS) in a research note released on Wednesday morning,Benzinga reports. Benchmark currently has a $1.25 target price on the stock.

Separately, StockNews.com began coverage on Milestone Scientific in a research report on Monday, November 18th. They set a “hold” rating for the company.

Milestone Scientific Stock Up 9.3 %

Shares of Milestone Scientific stock opened at $0.77 on Wednesday. The stock has a market cap of $60.29 million, a price-to-earnings ratio of -11.06 and a beta of 1.08. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10. The company’s fifty day moving average is $0.83 and its 200 day moving average is $0.84.

Insider Activity

In related news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the sale, the director now owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last three months, insiders have sold 109,193 shares of company stock valued at $101,634. 24.75% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Milestone Scientific

An institutional investor recently raised its position in Milestone Scientific stock. Geode Capital Management LLC grew its stake in shares of Milestone Scientific Inc. (NYSE:MLSS) by 6.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 527,005 shares of the company’s stock after purchasing an additional 31,572 shares during the period. Geode Capital Management LLC owned approximately 0.68% of Milestone Scientific worth $480,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.